vs

Side-by-side financial comparison of CLOVER HEALTH INVESTMENTS, CORP. (CLOV) and Talen Energy Corp (TLN). Click either name above to swap in a different company.

Talen Energy Corp is the larger business by last-quarter revenue ($758.0M vs $487.7M, roughly 1.6× CLOVER HEALTH INVESTMENTS, CORP.). CLOVER HEALTH INVESTMENTS, CORP. runs the higher net margin — -10.1% vs -47.9%, a 37.8% gap on every dollar of revenue. On growth, Talen Energy Corp posted the faster year-over-year revenue change (114.7% vs 44.7%). Talen Energy Corp produced more free cash flow last quarter ($254.0M vs $-69.0M). Over the past eight quarters, Talen Energy Corp's revenue compounded faster (35.0% CAGR vs 18.6%).

Clover Health Investments, Corp. is an American health care company founded in 2014. The company provides Medicare Advantage (MA) insurance plans and operates as a direct contracting entity with the U.S. government. The company manages care for Medicare beneficiaries in 11 states and started trading publicly on January 8, 2021.

PPL Corporation is an energy company headquartered in Allentown, Pennsylvania in the Lehigh Valley region of eastern Pennsylvania. The company is publicly traded on the New York Stock Exchange as NYSE: PPL and is part of the S&P 500. As of 2022, the company had $7.9 billion in revenue, 6,500 employees, over $37 billion in assets, and serves 3.6 million customers.

CLOV vs TLN — Head-to-Head

Bigger by revenue
TLN
TLN
1.6× larger
TLN
$758.0M
$487.7M
CLOV
Growing faster (revenue YoY)
TLN
TLN
+70.0% gap
TLN
114.7%
44.7%
CLOV
Higher net margin
CLOV
CLOV
37.8% more per $
CLOV
-10.1%
-47.9%
TLN
More free cash flow
TLN
TLN
$323.0M more FCF
TLN
$254.0M
$-69.0M
CLOV
Faster 2-yr revenue CAGR
TLN
TLN
Annualised
TLN
35.0%
18.6%
CLOV

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CLOV
CLOV
TLN
TLN
Revenue
$487.7M
$758.0M
Net Profit
$-49.3M
$-363.0M
Gross Margin
Operating Margin
-10.1%
-41.3%
Net Margin
-10.1%
-47.9%
Revenue YoY
44.7%
114.7%
Net Profit YoY
-123.2%
-542.7%
EPS (diluted)
$-7.60

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CLOV
CLOV
TLN
TLN
Q4 25
$487.7M
$758.0M
Q3 25
$496.6M
$697.0M
Q2 25
$477.6M
$409.0M
Q1 25
$462.3M
$654.0M
Q4 24
$337.0M
$353.0M
Q3 24
$331.0M
$459.0M
Q2 24
$356.3M
$346.0M
Q1 24
$346.9M
$416.0M
Net Profit
CLOV
CLOV
TLN
TLN
Q4 25
$-49.3M
$-363.0M
Q3 25
$-24.4M
$207.0M
Q2 25
$-10.6M
$72.0M
Q1 25
$-1.3M
$-135.0M
Q4 24
$-22.1M
$82.0M
Q3 24
$-9.2M
$168.0M
Q2 24
$7.4M
$454.0M
Q1 24
$-19.2M
$294.0M
Gross Margin
CLOV
CLOV
TLN
TLN
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
24.5%
Q2 24
30.3%
Q1 24
23.6%
Operating Margin
CLOV
CLOV
TLN
TLN
Q4 25
-10.1%
-41.3%
Q3 25
-4.9%
37.7%
Q2 25
-2.2%
16.1%
Q1 25
-0.3%
-16.2%
Q4 24
-6.4%
4.5%
Q3 24
-2.7%
34.4%
Q2 24
2.0%
7.8%
Q1 24
-6.5%
6.0%
Net Margin
CLOV
CLOV
TLN
TLN
Q4 25
-10.1%
-47.9%
Q3 25
-4.9%
29.7%
Q2 25
-2.2%
17.6%
Q1 25
-0.3%
-20.6%
Q4 24
-6.6%
23.2%
Q3 24
-2.8%
36.6%
Q2 24
2.1%
131.2%
Q1 24
-5.5%
70.7%
EPS (diluted)
CLOV
CLOV
TLN
TLN
Q4 25
$-7.60
Q3 25
$4.25
Q2 25
$1.50
Q1 25
$-2.94
Q4 24
$2.07
Q3 24
$3.16
Q2 24
$7.60
Q1 24
$4.84

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CLOV
CLOV
TLN
TLN
Cash + ST InvestmentsLiquidity on hand
$78.3M
$689.0M
Total DebtLower is stronger
$6.8B
Stockholders' EquityBook value
$308.7M
$1.1B
Total Assets
$541.0M
$10.9B
Debt / EquityLower = less leverage
6.23×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CLOV
CLOV
TLN
TLN
Q4 25
$78.3M
$689.0M
Q3 25
$497.0M
Q2 25
$122.0M
Q1 25
$295.0M
Q4 24
$194.5M
$328.0M
Q3 24
$288.0M
$648.0M
Q2 24
$254.8M
$632.0M
Q1 24
$208.3M
Total Debt
CLOV
CLOV
TLN
TLN
Q4 25
$6.8B
Q3 25
$3.0B
Q2 25
$3.0B
Q1 25
$3.0B
Q4 24
$3.0B
Q3 24
$2.6B
Q2 24
$2.6B
Q1 24
Stockholders' Equity
CLOV
CLOV
TLN
TLN
Q4 25
$308.7M
$1.1B
Q3 25
$340.9M
$1.5B
Q2 25
$344.2M
$1.2B
Q1 25
$336.1M
$1.2B
Q4 24
$341.1M
$1.4B
Q3 24
$342.2M
$2.4B
Q2 24
$324.9M
$2.5B
Q1 24
$292.5M
$2.8B
Total Assets
CLOV
CLOV
TLN
TLN
Q4 25
$541.0M
$10.9B
Q3 25
$559.7M
$6.1B
Q2 25
$575.0M
$5.8B
Q1 25
$583.7M
$5.9B
Q4 24
$580.7M
$6.1B
Q3 24
$653.0M
$6.8B
Q2 24
$674.2M
$7.1B
Q1 24
$671.8M
Debt / Equity
CLOV
CLOV
TLN
TLN
Q4 25
6.23×
Q3 25
2.03×
Q2 25
2.40×
Q1 25
2.54×
Q4 24
2.17×
Q3 24
1.10×
Q2 24
1.05×
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CLOV
CLOV
TLN
TLN
Operating Cash FlowLast quarter
$-66.9M
$280.0M
Free Cash FlowOCF − Capex
$-69.0M
$254.0M
FCF MarginFCF / Revenue
-14.1%
33.5%
Capex IntensityCapex / Revenue
0.4%
3.4%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-69.2M
$606.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CLOV
CLOV
TLN
TLN
Q4 25
$-66.9M
$280.0M
Q3 25
$12.1M
$489.0M
Q2 25
$5.4M
$-184.0M
Q1 25
$-16.3M
$119.0M
Q4 24
$34.8M
Q3 24
$50.0M
$96.0M
Q2 24
$44.8M
$-23.0M
Q1 24
$25.9M
$173.0M
Free Cash Flow
CLOV
CLOV
TLN
TLN
Q4 25
$-69.0M
$254.0M
Q3 25
$11.4M
$468.0M
Q2 25
$4.8M
$-217.0M
Q1 25
$-16.5M
$101.0M
Q4 24
$33.3M
Q3 24
$49.6M
$83.0M
Q2 24
$44.4M
$-43.0M
Q1 24
$25.5M
$148.0M
FCF Margin
CLOV
CLOV
TLN
TLN
Q4 25
-14.1%
33.5%
Q3 25
2.3%
67.1%
Q2 25
1.0%
-53.1%
Q1 25
-3.6%
15.4%
Q4 24
9.9%
Q3 24
15.0%
18.1%
Q2 24
12.5%
-12.4%
Q1 24
7.3%
35.6%
Capex Intensity
CLOV
CLOV
TLN
TLN
Q4 25
0.4%
3.4%
Q3 25
0.1%
3.0%
Q2 25
0.1%
8.1%
Q1 25
0.0%
2.8%
Q4 24
0.5%
Q3 24
0.1%
2.8%
Q2 24
0.1%
5.8%
Q1 24
0.1%
6.0%
Cash Conversion
CLOV
CLOV
TLN
TLN
Q4 25
Q3 25
2.36×
Q2 25
-2.56×
Q1 25
Q4 24
Q3 24
0.57×
Q2 24
6.04×
-0.05×
Q1 24
0.59×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CLOV
CLOV

Segment breakdown not available.

TLN
TLN

Electricity Sales And Ancillary Services$555.0M73%
Operating Revenue Capacity$182.0M24%
Physical Electricity Sales Bilateral Contracts Other$21.0M3%

Related Comparisons